Anavex Life Sciences

Anavex Life Sciences Corp., is a clinical-stage biopharmaceutical company focused on developing treatments for debilitating neurodegenerative and neurodevelopmental diseases. The Companys lead product candidate, ANAVEX2-73 is undergoing four mid- to late-stage clinical trial programs for CNS diseases where no good treatment options exist, or current treatments are inadequate. These include Alzheimers disease (Phase 2b/3) and Parkinsons disease dementia (Phase 2), which are neurodegenerative diseases that are on the rise due to aging populations in developed nations. Additionally, Anavex has two ongoing Phase 2 trials for Rett syndrome, a neurodevelopmental disease that mostly affects young female girls. Anavex has received Orphan...

Anavex life sciences operates in the Biotechnology research industry.

Anavex life sciences's HQ phone number is +1 844-689-3939

Anavex life sciences's revenue is 11m - 100m

Anavex life sciences has 51 - 200 employees.